SymbolSCNX
NameSCIENTURE HOLDINGS, INC.
SectorHEALTH CARE
RegionNorth America
IndustryOther Pharmaceuticals
Address3840 LAND O LAKES BOULEVARD,LAND O LAKES, PASCO, Florida, 34639, United States
Telephone+1 800 261-0281
Fax
Email
Websitevhttps://www.scienture.com
IncorporationUNDEFINED
Incorporated On
Employees
Fiscal Year
Public Since
ExchangesNASDAQ
Auditor
Audit StatusNOT PROVIDED
Reporting Status
CIK0001382574
Description

Scienture Holdings, Inc., formerly TRxADE Health, Inc., is a comprehensive health services and pharmaceutical product company focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs, optimize the prescription journey and patient engagement in the United States. It operates through Scienture, LLC and Integra Pharma Solutions, LLC. Scienture, LLC is a branded specialty pharmaceutical company. Its assets in development are across therapeutics areas, indications and cater to different market segments. Its products include SCN - 102 (Cardiovascular), SCN - 104 (CNS-Pain), SCN - 105 (CNS), SCN - 106 (Cardiovascular) and SCN - 107 (Pain). Integra Pharma Solutions, LLC is the pharmaceutical supplier of choice for healthcare organizations of all sizes. Its expertise in the distribution of products extends to all healthcare markets including government organizations, hospitals, clinics, and independent pharmacies nationwide.

Additional info from NASDAQ:
Scienture Holdings, Inc., formerly TRxADE Health, Inc., is a comprehensive health services and pharmaceutical product company focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs, optimize the prescription journey and patient engagement in the United States. It operates through Scienture, LLC and Integra Pharma Solutions, LLC. Scienture, LLC is a branded specialty pharmaceutical company. Its assets in development are across therapeutics areas, indications and cater to different market segments. Its products include SCN - 102 (Cardiovascular), SCN - 104 (CNS-Pain), SCN - 105 (CNS), SCN - 106 (Cardiovascular) and SCN - 107 (Pain). Integra Pharma Solutions, LLC is the pharmaceutical supplier of choice for healthcare organizations of all sizes. Its expertise in the distribution of products extends to all healthcare markets including government organizations, hospitals, clinics, and independent pharmacies nationwide.

2026-06-18 12:05

SCIENTURE Expands Arbli™ Payor Coverage and Commercial Access, Adding Approximately 12.5 Million Covered Lives Nationwide

Read more
2026-06-09 12:05

SCIENTURE Secures Formulary Coverage for REZENOPY™ with a Large National Health Plan and Expands Commercial Team

Read more
2026-06-02 12:05

SCIENTURE Receives U.S. Patent Covering REZENOPY™ (Naloxone HCl) Nasal Spray 10 mg, Strengthening Intellectual Property Protection Through 2041

Read more
2026-05-29 21:00

(99% Neutral) SCIENTURE HOLDINGS, INC. (SCNX) Announces New Board Appointment

Read more
2026-05-22 21:00

(30% Negative) SCIENTURE HOLDINGS, INC. (SCNX) Reports Q2 2026 Financial Results

Read more
2026-05-18 12:38

SCIENTURE Reports First Quarter 2026 Financial Results and Business Update Highlighted by Significant Revenue Growth and Gross Margin Expansion

Read more
2026-05-07 12:05

Scienture Secures $11.0 Million in Non-Dilutive Debt Financing to Accelerate Growth of Approved Product Portfolio and Advancement of R&D Pipeline

Read more
2026-05-06 12:05

SCIENTURE Announces Third Patent Grant for ARBLI™ (losartan potassium) Oral Suspension, Strengthening Long-Term Market Exclusivity Through 2041

Read more
2026-05-01 21:25

(30% Negative) SCIENTURE HOLDINGS, INC. (SCNX) Announces Business Combination

Read more
2026-04-30 18:01

New Form 10-K/A - Scienture Holdings, Inc. <b>Filed:</b> 2026-04-30 <b>AccNo:</b> 0001493152-26-020707 <b>Size:</b> 937 KB

Read more